The principles, design and applications of fused-ring electron acceptors
Fused-ring electron acceptors (FREAs) have a donor–acceptor–donor structure comprising
an electron-donating fused-ring core, electron-accepting end groups, π-bridges and side …
an electron-donating fused-ring core, electron-accepting end groups, π-bridges and side …
Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy
TC Pham, VN Nguyen, Y Choi, S Lee, J Yoon - Chemical reviews, 2021 - ACS Publications
This review presents a robust strategy to design photosensitizers (PSs) for various species.
Photodynamic therapy (PDT) is a photochemical-based treatment approach that involves the …
Photodynamic therapy (PDT) is a photochemical-based treatment approach that involves the …
Acceptor Planarization and Donor Rotation: A Facile Strategy for Realizing Synergistic Cancer Phototherapy via Type I PDT and PTT
L Feng, C Li, L Liu, Z Wang, Z Chen, J Yu, W Ji… - ACS …, 2022 - ACS Publications
Tumor hypoxia seriously impairs the therapeutic outcomes of type II photodynamic therapy
(PDT), which is highly dependent upon tissue oxygen concentration. Herein, a facile strategy …
(PDT), which is highly dependent upon tissue oxygen concentration. Herein, a facile strategy …
Coupling probiotics with 2D CoCuMo‐LDH nanosheets as a tumor‐microenvironment‐responsive platform for precise NIR‐II photodynamic therapy
Y Yang, T Hu, Y Bian, F Meng, S Yu, H Li… - Advanced …, 2023 - Wiley Online Library
Photodynamic therapy (PDT) has become a promising cancer treatment approach with
superior advantages. However, it remains a grand challenge to develop tumor …
superior advantages. However, it remains a grand challenge to develop tumor …
BODIPY‐based photodynamic agents for exclusively generating superoxide radical over singlet oxygen
Develo** Type‐I photosensitizers is considered as an efficient approach to overcome the
deficiency of traditional photodynamic therapy (PDT) for hypoxic tumors. However, it remains …
deficiency of traditional photodynamic therapy (PDT) for hypoxic tumors. However, it remains …
Achieving efficient NIR‐II type‐I photosensitizers for photodynamic/photothermal therapy upon regulating chalcogen elements
K Wen, H Tan, Q Peng, H Chen, H Ma… - Advanced …, 2022 - Wiley Online Library
Second near‐infrared (NIR‐II) window type‐I photosensitizers have intrinsic advantages in
photodynamic/photothermal therapy (PDT/PTT) of some malignant tumors with deep …
photodynamic/photothermal therapy (PDT/PTT) of some malignant tumors with deep …
Fluorination enhances NIR‐II emission and photothermal conversion efficiency of phototheranostic agents for imaging‐guided cancer therapy
C Li, G Jiang, J Yu, W Ji, L Liu, P Zhang… - Advanced …, 2023 - Wiley Online Library
Phototheranostics with second near‐infrared (NIR‐II) imaging and photothermal effect have
become a burgeoning biotechnology for tumor diagnosis and precise treatment. As …
become a burgeoning biotechnology for tumor diagnosis and precise treatment. As …
Efficient NIR-II type-I AIE photosensitizer for mitochondria-targeted photodynamic therapy through synergistic apoptosis–ferroptosis
J Zhuang, B Wang, H Chen, K Zhang, N Li, N Zhao… - ACS …, 2023 - ACS Publications
Hypoxia, the hallmark of malignant tumors, has been recognized as a major obstacle for
photodynamic therapy (PDT). Precisely targeting cancer cells in intricate biological …
photodynamic therapy (PDT). Precisely targeting cancer cells in intricate biological …
Cationization-enhanced type I and type II ROS generation for photodynamic treatment of drug-resistant bacteria
Photodynamic therapy as an emerging phototheranostic approach holds great potential for
antibacterial treatment, but is limited by compromised reactive oxygen species (ROS) …
antibacterial treatment, but is limited by compromised reactive oxygen species (ROS) …
Copper‐Bacteriochlorin Nanosheet as a Specific Pyroptosis Inducer for Robust Tumor Immunotherapy
Y Zhang, Q Jia, J Li, J Wang, K Liang, X Xue… - Advanced …, 2023 - Wiley Online Library
Pyroptosis is increasingly considered a new weathervane in cancer immune therapy.
However, triggering specific pyroptotic tumor cell death while preserving normal cells still …
However, triggering specific pyroptotic tumor cell death while preserving normal cells still …